Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation

Journal of Magnetic Resonance Imaging

Volumn 41, Issue 6, 2015, Pages 1646-1653

  Intven, Martijn ^a   Reerink, Onne ^a   Philippens, Marielle E P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

chemoradiotherapy; dynamic contrast enhanced MRI; organ sparing treatments; rectal cancer; therapy response

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOROURACIL; GADOBUTROL; CONTRAST MEDIUM;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SIZE; CANCER SURGERY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLOGICAL PARAMETERS; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECTUM CANCER; TREATMENT DURATION; TREATMENT RESPONSE; VOLUME TRANSFER CONSTANT; ADJUVANT CHEMORADIOTHERAPY; CANCER GRADING; CANCER STAGING; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RECTAL NEOPLASMS; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; CHEMORADIOTHERAPY, ADJUVANT; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM GRADING; NEOPLASM STAGING; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84930046423     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24718     Document Type: Article

References (32)

1. Sauer R, Becker H, Hohenberger W, et al., Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
2. Valentini V, Aristei C, Glimelius B, et al., Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2). Radiother Oncol 2009; 92: 148-163.
3. Habr-Gama A, Perez RO, Proscurshim I, et al., Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10: 1319-1328.
4. Borschitz T, Wachtlin D, Mohler M, et al., Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008; 15: 712-720.
5. Maas M, Beets-Tan RG, Lambregts DM, et al., Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011; 29: 4633-4640.
6. Allaix ME, Fichera A,. Modern rectal cancer multidisciplinary treatment: the role of radiation and surgery. Ann Surg Oncol 2013; 20: 2921-2928.
7. Lambregts DM, Vandecaveye V, Barbaro B, et al., Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011; 18: 2224-2231.
8. Intven M, Reerink O, Philippens ME,. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol 2012; 189: 117-122.
9. Engelen SM, Beets-Tan RG, Lahaye MJ, et al., MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision. Dis Colon Rectum 2010; 53: 979-986.
10. Janssen MH, Ollers MC, Riedl RG, et al., Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys 2010; 77: 392-399.
11. Li SP, Padhani AR,. Tumor response assessments with diffusion and perfusion MRI. J Magn Reson Imaging 2012; 35: 745-763.
12. Rudisch A, Kremser C, Judmaier W, et al., Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. Eur J Radiol 2005; 53: 514-519.
13. Kim MJ, Park JS, Park SI, et al., Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr 2003; 27: 48-55.
14. Tofts PS, Brix G, Buckley DL, et al., Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
15. Murase K,. Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Med 2004; 51: 858-862.
16. Groenendaal G, Borren A, Moman MR, et al., Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone. Int J Radiat Oncol Biol Phys 2012; 82: e537-e544.
17. Bol GH, Kotte AN, van der Heide UA, et al., Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed 2009; 96: 133-140.
18. Quirke P, Morris E,. Reporting colorectal cancer. Histopathology 2007; 50: 103-112.
19. Mandard AM, Dalibard F, Mandard JC, et al., Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. clinicopathologic correlations. Cancer 1994; 73: 2680-2686.
20. Hanley JA, McNeil BJ,. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843.
21. George ML, Dzik-Jurasz AS, Padhani AR, et al., Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001; 88: 1628-1636.
22. DeVries AF, Kremser C, Hein PA, et al., Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003; 56: 958-965.
23. Kim SH, Lee JM, Gupta SN, et al., Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Magn Reson Imaging 2013. [Epub ahead of print] doi: 10.1002/jmri.24387.
24. Lim JS, Kim D, Baek SE, et al., Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2012; 22: 1693-1700.
25. Cooper RA, Carrington BM, Loncaster JA, et al., Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 2000; 57: 53-59.
26. de Lussanet QG, Backes WH, Griffioen AW, et al., Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1309-1315.
27. Yeo DM, Oh SN, Jung CK, et al., Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: preliminary results. J Magn Reson Imaging 2013. [Epub ahead of print] doi: 10.1002/jmri.24541.
28. Nougaret S, Fujii S, Addley HC, et al., Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: initial experience. J Magn Reson Imaging 2013; 38: 726-732.
29. van der Paardt MP, Zagers MB, Beets-Tan RG, et al., Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 2013; 269: 101-112.
30. Mawlawi O, Townsend DW,. Multimodality imaging: an update on PET/CT technology. Eur J Nucl Med Mol Imaging 2009; 36 (Suppl 1): S15-S29.
31. Lambrecht M, Vandecaveye V, De Keyzer F, et al., Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 2011; 82: 63-70.
32. Zhang C, Tong J, Sun X, et al., 18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis. Int J Cancer 2012; 131: 2604-2611.